Nimble Therapeutics
Latest round
- Series A
Last raised
- Apr 2019
Total raised
- $10M
Investors
- 2
About Nimble Therapeutics
Based in Wisconsin, US, and founded in 2019, Nimble Therapeutics, Inc. operates as a biotech company that focuses on developing oral therapies for immune-mediated diseases. Nimble leverages its proprietary discovery engine to create therapies that replicate the benefits of established treatments. In December 2024, AbbVie agreed to acquire Nimble Therapeutics, Inc. from Roche Venture Fund and Telegraph Hill Partners for USD 200 million in cash. Nimble Therapeutics specializes in advanced drug discovery technologies, focusing primarily on immunology and therapeutics. The company is dedicated to developing breakthrough medicines through its proprietary platforms, which facilitate the identification and optimization of novel therapeutic candidates. These technologies aim to address a variety of diseases by enhancing the therapeutic efficacy and safety profiles of drug candidates. Nimble Therapeutics serves a diverse client base, which includes pharmaceutical companies and research institutions seeking to advance their drug development pipelines. Nimble Therapeutics generates revenue through strategic partnerships and collaborations with major pharmaceutical firms. The transaction structure typically involves B2B arrangements, where clients engage the company for its drug discovery services and technologies.
Who invested in Nimble Therapeutics
2 investors across 1 round
See all investors in Nimble Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Apr 2, 2019
Amount
$10M
Investors
Questions about Nimble Therapeutics
Who invested in Nimble Therapeutics?
Nimble Therapeutics has 2 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Nimble Therapeutics raised?
Nimble Therapeutics has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Nimble Therapeutics last raise money?
Nimble Therapeutics's most recent round on record is a Series A, in Apr 2019.
What does Nimble Therapeutics do?
Based in Wisconsin, US, and founded in 2019, Nimble Therapeutics, Inc.
Where is Nimble Therapeutics headquartered?
Nimble Therapeutics is headquartered in Madison, US.
Which VCs invest in companies like Nimble Therapeutics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Nimble Therapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Nimble Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.